What is XWIN's health score?

XMax Inc. (XWIN) has a TradeApes health score of 39 out of 100, rated Weak. This composite score evaluates financial strength, operating trends, valuation, capital allocation, and risk factors.

What is XWIN's estimated fair value?

Based on our 5-year discounted cash flow model, XMax Inc.'s estimated fair value is $N/A per share. This is a model estimate, not a price target or investment recommendation.

Is XWIN undervalued or overvalued?

Our model currently rates XWIN as Inconclusive. This assessment combines health metrics, valuation multiples, and market sentiment. Individual investors should conduct their own due diligence.

Crunching the numbers for XWIN... Refresh in a moment for the full analysis.

XMax Inc. (XWIN)

Consumer Cyclical Inconclusive inconclusive weak

$8.24

Updated: 2026-06-06

TradeApes Score

Financial Strength

20 Stressed

Operating Trend

65 Healthy

Relative Value

40 Weak

Capital Allocation

10 Stressed

Risk

65 Healthy

Key Findings

+ Strong revenue growth — sales up more than 20% year over year

Unlock Full Report →

− High leverage — net debt/EBITDA between 3× and 5×

Unlock Full Report →

3 free score cards remaining

TradeApes provides financial data, analytics, and research tools. TradeApes is not a registered investment adviser, broker-dealer, or tax advisor. The information presented is for educational and informational purposes only and does not constitute investment, financial, or tax advice.

11 sector-leading stocks delivered to your inbox every Sunday. Free.

No spam. Unsubscribe anytime.